semaglutide gastric intestinal obstruction law office in michigan Weight Loss Drugs Lawsuit Do you believe in magic?

Most GLP-1 users eat far less protein than they need during weight loss

Cardiovascular protective properties of GLP-1 receptor agonists: more than just diabetic and weight loss drugs

Research into GLP-1 receptor antagonists (such as exendin 9-39) for treating PBH is ongoing, but these remain investigational and are not currently licensed for this indication in the UK

The key takeaway: weight regain after stopping medication is the expected biological response, not an exception

Summary: Mounjaro (tirzepatide) does not directly lower potassium levels, and hypokalaemia is not a recognised adverse effect in clinical trials or regulatory guidance